Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Vir Biotechnology (VIR)
NASDAQ:VIR
Vir Biotechnology (VIR) Stock Price & Analysis
916 Followers
VIR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$18.05 - $34.97
Previous Close$30.14
Volume859.72K
Average Volume (3M)832.48K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$2.35B
Total Debt (Recent Filing)$131.06M
Price to Earnings (P/E)3.5
Beta1.34
Next EarningsFeb 23, 2023
EPS Estimate-$0.35
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price Target$57.50
EPS (TTM)8.50
Shares Outstanding133,115,621
R-Squared0.00101
Standard Deviation0.35
10 Day Avg. Volume911,374
30 Day Avg. Volume832,477
Price to Book (P/B)1.87
Price to Sales (P/S)2.49
Price to Cash Flow (P/CF)2.40
P/FCF Ratio2.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside90.78% Upside
Rating ConsensusStrong Buy
Alpha0.06
Number of Analyst Covering4
Vir Biotechnology News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
VIR FAQ
What was Vir Biotechnology’s price range in the past 12 months?
Vir Biotechnology lowest stock price was $18.05 and its highest was $34.97 in the past 12 months.
What is Vir Biotechnology’s market cap?
Currently, no data Available
When is Vir Biotechnology’s upcoming earnings report date?
Vir Biotechnology’s upcoming earnings report date is Feb 23, 2023 which is in 19 days.
How were Vir Biotechnology’s earnings last quarter?
Vir Biotechnology released its earnings results on Nov 03, 2022. The company reported $1.3 earnings per share for the quarter, beating the consensus estimate of -$0.508 by $1.808.
Is Vir Biotechnology overvalued?
According to Wall Street analysts Vir Biotechnology’s price is currently Undervalued.
Does Vir Biotechnology pay dividends?
Vir Biotechnology does not currently pay dividends.
What is Vir Biotechnology’s EPS estimate?
Vir Biotechnology’s EPS estimate is -$0.35.
How many shares outstanding does Vir Biotechnology have?
Vir Biotechnology has 133,115,620 shares outstanding.
What happened to Vir Biotechnology’s price movement after its last earnings report?
Vir Biotechnology reported an EPS of $1.3 in its last earnings report, beating expectations of -$0.508. Following the earnings report the stock price went up 17.706%.
Which hedge fund is a major shareholder of Vir Biotechnology?
Among the largest hedge funds holding Vir Biotechnology’s share is Gotham Asset Management LLC. It holds Vir Biotechnology’s shares valued at 1M.
---
Vir Biotechnology Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$57.50
$57.50
Blogger Sentiment
Bullish
VIR Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 51.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days <0.1%
Last 30 Days ▲ 8.2%
Last 30 Days ▲ 8.2%
News Sentiment
Neutral
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-9.92%
12-Months-Change
Fundamentals
Return on Equity
75.52%
Trailing 12-Months
Asset Growth
122.77%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Vir Biotechnology
Vir Biotechnology, Inc. engages in the provision of technologies to treat and prevent infectious diseases. Its technology platforms include antibody, T cell, innate immunity, and siRNA. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in 2016 and is headquartered in San Francisco, CA.
---
---